Massachusetts bill H5550 restricts the use of DEHP in intravenous solutions and tubing.
Massachusetts bill H5550 amends the General Laws to restrict the use of Di(2-ethylhexyl)phthalate (DEHP) in intravenous solutions and tubing. Specifically, it prohibits the manufacture, sale, or distribution of intravenous solution containers and tubing products containing intentionally added DEHP, except where it serves a functional or technical purpose. The bill also bans replacing DEHP with other ortho-phthalates in new or revised products. The provisions take effect on January 1, 2030, and January 1, 2035, respectively.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.